Influenza
- PMID: 10520648
- DOI: 10.1016/S0140-6736(99)01241-6
Influenza
Abstract
Influenza is the most frequent cause of acute respiratory illness requiring medical intervention because it affects all age groups and because it can recur in any individual. During the past three decades, efforts to prevent and control influenza have focused primarily on the use of inactivated influenza vaccines in elderly people and in individuals with chronic medical conditions that put them at risk for complications. However, the continuing impact of influenza in these and other population groups has motivated the development of novel approaches for prevention and control of influenza. Several important advances in the field of influenza have occurred in the last few years. An experimental live, attenuated, intranasally administered trivalent influenza vaccine was shown to be highly effective in protecting young children against influenza A H3N2 and influenza B. New antiviral drugs based on the structure of the neuraminidase molecule were assessed in clinical trials and found to be effective against influenza A and B viruses. The expected use of these new antiviral agents has accelerated the development of rapid point-of-care diagnostic tests. The availability of new diagnostic tests, new antiviral drugs, and new vaccines will undoubtedly alter our approaches to influenza control and have an impact on clinical practice.
Similar articles
-
Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.Pediatrics. 2007 Sep;120(3):e553-64. doi: 10.1542/peds.2006-2836. Epub 2007 Aug 13. Pediatrics. 2007. PMID: 17698577 Clinical Trial.
-
[Influenza].Recenti Prog Med. 2000 Dec;91(12):657-66. Recenti Prog Med. 2000. PMID: 11194487 Review. Italian.
-
Influenza: epidemiology, clinical features, therapy, and prevention.Semin Respir Crit Care Med. 2011 Aug;32(4):373-92. doi: 10.1055/s-0031-1283278. Epub 2011 Aug 19. Semin Respir Crit Care Med. 2011. PMID: 21858743 Review.
-
Advances in the prophylaxis and treatment of influenza illness. Based on a presentation by Frederick G. Hayden, MD.Am J Manag Care. 2000 Mar;6(5 Suppl):S247-54. Am J Manag Care. 2000. PMID: 10977471
-
Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice.Prescrire Int. 2013 Sep;22(141):201-4. Prescrire Int. 2013. PMID: 24171209
Cited by
-
Decreased Risk of Influenza in Child and Adolescent Patients with Attention-Deficit Hyperactivity Disorder Following Methylphenidate Treatment: A Nationwide Cohort Study in Taiwan.Neuropsychiatr Dis Treat. 2020 May 21;16:1309-1319. doi: 10.2147/NDT.S242519. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32547034 Free PMC article.
-
Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).Hum Vaccin Immunother. 2015;11(8):2077-101. doi: 10.1080/21645515.2015.1027470. Hum Vaccin Immunother. 2015. PMID: 26042462 Free PMC article.
-
Parental risk perception and influenza vaccination of children in daycare centres.Epidemiol Infect. 2014 Jan;142(1):134-41. doi: 10.1017/S0950268813000782. Epub 2013 Apr 18. Epidemiol Infect. 2014. PMID: 23594431 Free PMC article.
-
[Bilateral influenza-triggered panuveitis and subsequent therapy with amantadine and hyperimmunoglobulins].Ophthalmologe. 2004 Jul;101(7):720-4. doi: 10.1007/s00347-003-0899-7. Ophthalmologe. 2004. PMID: 15309488 German.
-
An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice.J Virol. 2010 Sep;84(17):8639-49. doi: 10.1128/JVI.00596-10. Epub 2010 Jun 10. J Virol. 2010. PMID: 20538850 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous